Year |
Citation |
Score |
2024 |
Meng CF, Lee Y, Schieir O, Valois MF, Butler M, Boire G, Hazlewood G, Hitchon C, Keystone E, Tin D, Thorne C, Bessette L, Pope J, Bartlett S, Bykerk V. Having More Tender Than Swollen Joints is Associated With Worse Function and Work Impairment in Patients With Early Rheumatoid Arthritis. Acr Open Rheumatology. PMID 38446125 DOI: 10.1002/acr2.11658 |
0.322 |
|
2022 |
Bartlett SJ, Bykerk VP, Schieir O, Valois MF, Pope JE, Boire G, Hitchon C, Hazlewood G, Bessette L, Keystone E, Thorne C, Tin D, Bingham CO. "From Where I Stand": using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ). Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 36074252 DOI: 10.1007/s11136-022-03227-7 |
0.314 |
|
2020 |
Fatima S, Schieir O, Valois MF, Bartlett SJ, Bessette L, Boire G, Hazlewood G, Hitchon C, Keystone EC, Tin D, Thorne C, Bykerk VP, Pope JE. Health Assessment Questionnaire at One Year Predicts All-Cause Mortality in Patients with Early Rheumatoid Arthritis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 32892510 DOI: 10.1002/Art.41513 |
0.389 |
|
2020 |
Holdren M, Schieir O, Bartlett SJ, Bessette L, Boire G, Hazlewood G, Hitchon CA, Keystone E, Tin D, Thorne C, Bykerk VP, Pope JE. Improvements in Fatigue Lag Behind Disease Remission in Early Rheumatoid Arthritis: Results from the Canadian Early Arthritis Cohort. Arthritis & Rheumatology (Hoboken, N.J.). PMID 32852109 DOI: 10.1002/Art.41499 |
0.425 |
|
2020 |
Allard-Chamard H, Carrier N, Dufort P, Durand M, de Brum-Fernandes AJ, Boire G, Komarova SV, Dixon SJ, Harrison RE, Manolson MF, Roux S. Osteoclasts and their circulating precursors in rheumatoid arthritis: Relationships with disease activity and bone erosions. Bone Reports. 12: 100282. PMID 32478145 DOI: 10.1016/J.Bonr.2020.100282 |
0.403 |
|
2020 |
Carrier N, de Brum-Fernandes AJ, Liang P, Masetto A, Roux S, Biln NK, Maksymowych WP, Boire G. Impending radiographic erosive progression over the following year in a cohort of consecutive patients with inflammatory polyarthritis: prediction by serum biomarkers. Rmd Open. 6. PMID 32371434 DOI: 10.1136/Rmdopen-2020-001191 |
0.309 |
|
2020 |
Ramiro S, Landewé RB, van der Heijde D, Sepriano A, FitzGerald O, Ostergaard M, Homik J, Elkayam O, Thorne JC, Larche M, Ferraciolli G, Backhaus M, Boire G, Combe B, Schaeverbeke T, et al. Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM). Annals of the Rheumatic Diseases. PMID 32094157 DOI: 10.1136/Annrheumdis-2019-216819 |
0.403 |
|
2020 |
Rezaei E, Hogan D, Trost B, Kusalik AJ, Boire G, Cabral DA, Campillo S, Chédeville G, Chetaille AL, Dancey P, Duffy C, Watanabe Duffy K, Gordon J, Guzman J, Houghton K, et al. Clinical and associated inflammatory biomarker features predictive of short-term outcomes in non-systemic juvenile idiopathic arthritis. Rheumatology (Oxford, England). PMID 31919503 DOI: 10.1093/Rheumatology/Kez615 |
0.337 |
|
2020 |
Gaboury I, Dobkin P, Roberge P, Beaulieu M, Dagenais P, Roux S, Boire G. Mindfulness-Based Reduction Stress Reduction for Patients with Rheumatoid Arthritis and Depressive Symptoms: a Pilot Trial International Journal of Whole Person Care. 7: 7-8. DOI: 10.26443/Ijwpc.V7I1.210 |
0.357 |
|
2020 |
Carrier N, Roux S, Masetto A, Fernandes AJD, Liang P, Maoui M, Boire G. Fri0031 Observations On Biomarkers In Very Early Rheumatoid Arthritis Consecutively Recruited Over 20 Years, From Baseline Presentation To Five-Year Outcomes Annals of the Rheumatic Diseases. 79: 588-589. DOI: 10.1136/Annrheumdis-2020-Eular.717 |
0.348 |
|
2020 |
Beaulieu MC, Gaboury I, Carrier N, Dobkin P, Gervais F, Gendron F, Roberge P, Dagenais P, Roux S, Boire G. Pare0016 Mindfulness-Based Stress Reduction To Improve Depressive Symptoms And Rheumatoid Arthritis-Related Clinical Outcomes: Results From A Feasibility And Acceptability Trial Annals of the Rheumatic Diseases. 79: 1294-1294. DOI: 10.1136/Annrheumdis-2020-Eular.6339 |
0.425 |
|
2020 |
Andersen N, Schieir O, Valois MF, Boire G, Pope J, Hazlewood G, Bessette L, Hitchon C, Tin D, Thorne C, Keystone E, Bykerk V, Bartlett SJ. Op0263-Hpr Major Stressors In The Year Prior To Ra Diagnosis: Impact On Patient-Reported Outcomes One Year Later Annals of the Rheumatic Diseases. 79: 165-165. DOI: 10.1136/Annrheumdis-2020-Eular.4826 |
0.364 |
|
2020 |
Bykerk V, Schieir O, Valois MF, Bessette L, Boire G, Hazlewood G, Hitchon C, Keystone E, Tin D, Thorne C, Pope J, Bartlett SJ. Fri0032 Regional And Widespread Patterns Of Non-Articular Pain Are Common At Ra Diagnosis And Contribute To Poor Outcomes At 12 Months: A Prospective Study Of Pain Patterns In Canadians With Ra Annals of the Rheumatic Diseases. 79: 585-586. DOI: 10.1136/Annrheumdis-2020-Eular.3902 |
0.395 |
|
2020 |
Fatima S, Schieir O, Valois MF, Bartlett SJ, Bessette L, Boire G, Hazlewood G, Hitchon C, Keystone E, Tin D, Thorne C, Bykerk V, Pope J. Fri0037 All-Cause Mortality In Early Rheumatoid Arthritis Predicted By Health Assessment Questionnaire At One Year Annals of the Rheumatic Diseases. 79: 588-589. DOI: 10.1136/Annrheumdis-2020-Eular.2508 |
0.389 |
|
2020 |
Weiler M, Schieir O, Valois MF, Bartlett SJ, Bessette L, Boire G, Hazlewood G, Hitchon C, Keystone E, Tin D, Thorne C, Bykerk V, Pope J. Sat0127 Real-World Predictors Of Starting Different Advanced Dmard Treatments In Rheumatoid Arthritis: A Prospective Investigation From The Canadian Early Arthritis Cohort (Catch) Group Annals of the Rheumatic Diseases. 79: 995-996. DOI: 10.1136/Annrheumdis-2020-Eular.2063 |
0.368 |
|
2020 |
Moura CS, Choquette D, Coupal L, Schieir O, Valois MF, Bykerk V, Boire G, Maksymowych WP, Bernatsky S. Thu0179 Persistence In Rheumatoid Arthritis Patients On Biosimilar And Bio-Originator Etanercept: A Pooled Analysis Of Pan-Canadian Cohorts Annals of the Rheumatic Diseases. 79: 306-307. DOI: 10.1136/Annrheumdis-2020-Eular.1746 |
0.356 |
|
2019 |
Ellingwood L, Kudaeva F, Schieir O, Bartlett SJ, Bessette L, Boire G, Hazlewood GS, Hitchon C, Keystone E, Tin D, Thorne C, Bykerk VP, Pope J. A quarter of patients time their early rheumatoid arthritis onset differently than physicians. Rmd Open. 5: e000931. PMID 31803498 DOI: 10.1136/Rmdopen-2019-000931 |
0.429 |
|
2019 |
Allard-Chamard H, Boire G. Serologic Diagnosis of Rheumatoid Arthritis. Clinics in Laboratory Medicine. 39: 525-537. PMID 31668267 DOI: 10.1016/J.Cll.2019.07.002 |
0.402 |
|
2019 |
Moura CS, Schieir O, Valois MF, Thorne C, Bartlett SJ, Pope JE, Hitchon CA, Boire G, Haraoui B, Hazlewood GS, Keystone EC, Tin D, Bykerk VP, Bernatsky S. Treatment strategies in early rheumatoid arthritis methotrexate management: Results from a prospective cohort. Arthritis Care & Research. PMID 31112011 DOI: 10.1002/Acr.23927 |
0.375 |
|
2019 |
Chhabra A, Oen K, Huber AM, Shiff NJ, Boire G, Benseler SM, Berard RA, Scuccimarri R, Feldman BM, Lim LSH, Barsalou J, Bruns A, Cabral DA, Chédeville G, Ellsworth J, et al. Real-World Effectiveness of Common Treatment Strategies for Juvenile Idiopathic Arthritis: Results from a Canadian Cohort. Arthritis Care & Research. PMID 31074591 DOI: 10.1002/Acr.23922 |
0.305 |
|
2019 |
Bartlett SJ, Schieir O, Valois M, Hitchon C, Bessette L, Hazlewood G, Thorne C, Pope J, Boire G, Tin D, Keystone E, Bykerk V, Investigators C. Op0269 Hpr Patterns Of Fatigue And Predictors Of Significant Improvement In The 1St Year Of Ra: Results From The Canadian Early Arthritis Cohort (Catch) Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.6357 |
0.402 |
|
2019 |
Bartlett SJ, Schieir O, Valois M, Pope J, Bessette L, Hitchon C, Thorne C, Tin D, Hazlewood G, Boire G, Keystone E, Bykerk V. Thu0658 Who Is At Risk For Persistent Fatigue In The First Year Of Ra? Characteristics Of Patients With Persistent Fatigue In The First Year By Sex In The Canadian Early Arthritis Cohort (Catch) Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.6356 |
0.395 |
|
2019 |
Kuriya B, Schieir O, Valois M, Pope J, Boire G, Bessette L, Hazlewood G, Thorne C, Tin D, Hitchon C, Bartlett SJ, Keystone E, Bykerk V, Barra L. Op0089 Metabolic Syndrome Is Common Around The Time Of Early Rheumatoid Arthritis Diagnosis And Associations Vary By Sex And Menopausal Status: Results From The Canadian Early Arthritis Cohort Annals of the Rheumatic Diseases. 78: 117-117. DOI: 10.1136/Annrheumdis-2019-Eular.5654 |
0.378 |
|
2019 |
Bykerk V, Schieir O, Valois M, Hazlewood G, Boire G, Hitchon C, Bessette L, Thorne C, Keystone E, Tin D, Benson C, Pope J, Bingham C, Bartlett SJ. Ab1304 The Rheumatoid Arthritis Flare Questionnaire (Ra-Fq) Is An Easy To Administer Patient-Reported Outcome Measure That Tracks Well With The Clinical Disease Activity Index (Cdai) Over Time In Patients With Early Rheumatoid Arthritis (Era) In 2 Different Health Settings Annals of the Rheumatic Diseases. 78: 2114-2115. DOI: 10.1136/Annrheumdis-2019-Eular.4977 |
0.451 |
|
2019 |
Holdren M, Schieir O, Bartlett SJ, Bessette L, Boire G, Hazlewood G, Hitchon C, Keystone E, Tin D, Thorne C, Bykerk V, Pope J. Op0315 Achieving A Low Disease State Within First 3 Months In Early Rheumatoid Arthritis Results In Lower Fatigue Over 5 Years Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.4414 |
0.376 |
|
2019 |
Ellingwood L, Schieir O, Valois M, Bartlett SJ, Bessette L, Hitchon C, Boire G, Hazlewood G, Keystone E, Tin D, Thorne C, Bykerk V, Pope J. Fri0065 Patient-Reported Palindromic Symptoms In Early Rheumatoid Arthritis: Results From The Canadian Early Arthritis Cohort Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.2458 |
0.41 |
|
2019 |
Powell M, Bykerk V, Schieir O, Pope J, Bartlett SJ, Bessette L, Boire G, Hitchon C, Keystone E, Thorne C, Tin D, Valois M, Hazlewood G. Thu0153 Patterns Of Sustained Remission And Subsequent Dmard Tapering In Early Rheumatoid Arthritis: Data From The Canadian Early Arthritis Cohort Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.2320 |
0.399 |
|
2018 |
Lee JJY, Duffy CM, Guzman J, Oen K, Barrowman N, Rosenberg AM, Shiff NJ, Boire G, Stringer E, Spiegel L, Morishita KA, Lang B, Reddy D, Huber AM, Cabral DA, et al. Prospective Determination of the Incidence and Risk Factors of New-Onset Uveitis in Juvenile Idiopathic Arthritis: The Research in Arthritis in Canadian Children Emphasizing Outcomes Cohort. Arthritis Care & Research. PMID 30320957 DOI: 10.1002/Acr.23783 |
0.336 |
|
2018 |
Dobkin PL, Boire G. Controlled Joint Inflammation but Still No Remission? It's Time to Attend to Depressive Symptoms. The Journal of Rheumatology. 45: 585-587. PMID 29717092 DOI: 10.3899/Jrheum.170801 |
0.388 |
|
2018 |
Barber CEH, Schieir O, Lacaille D, Marshall DA, Barnabe C, Hazlewood G, Thorne C, Ahluwalia V, Bartlett SJ, Boire G, Haraoui B, Hitchon CA, Keystone E, Tin D, Pope J, et al. High Adherence Observed to System-Level Performance Measures for Rheumatoid Arthritis in a National Early Arthritis Cohort Over 8 Years. Arthritis Care & Research. PMID 29450976 DOI: 10.1002/Acr.23439 |
0.396 |
|
2018 |
Roux S, Cabana F, Carrier N, Beaulieu MC, Boire G. Risk of Subsequent Fragility Fractures Observed After Low-Trauma Ankle Fractures. Calcified Tissue International. PMID 29356845 DOI: 10.1007/S00223-018-0393-5 |
0.325 |
|
2018 |
Dobkin PL, Boire G. Playing jeopardy by not treating the whole person with arthritis International Journal of Whole Person Care. 5. DOI: 10.26443/Ijwpc.V5I1.150 |
0.362 |
|
2018 |
Schieir O, Bartlett SJ, Valois M-, Pope JE, Thorne C, Hitchon C, Haraoui B, Boire G, Tin D, Keystone EC, Bykerk VP. SAT0080 Secular trends prior to-and after dissemination of best practice recommendations showed earlier intensified medication strategies and improved outcomes in canadians with early inflammatory arthritis Annals of the Rheumatic Diseases. 77: 902-903. DOI: 10.1136/Annrheumdis-2018-Eular.7268 |
0.456 |
|
2018 |
Bykerk VP, Schieir O, Valois M-, Keystone EC, Boire G, Pope JE, Tin D, Haraoui B, Hitchon C, Thorne C, Bartlett SJ. THU0132 The patient global assessment rating varies minimally if using arthritis or global health condition and agreement is high between common composite disease activitymeasures and remission classification using either: results from a national early ra cohort study Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2018-Eular.6028 |
0.396 |
|
2018 |
Bartlett SJ, Schieir O, Valois M-, Hitchon C, Boire G, Haraoui B, Thorne C, Tin D, Pope J, Keystone EC, Bykerk VP. OP0106 Who is not reaching remission in early ra and why? predictors for persistent disease activity in the first year differ in men and women and are related to lifestyle and treatment Annals of the Rheumatic Diseases. 77: 103-104. DOI: 10.1136/Annrheumdis-2018-Eular.5848 |
0.392 |
|
2018 |
Bartlett SJ, Schieir O, Valois M-, Haraoui B, Boire G, Thorne C, Hitchon C, Tin D, Keystone EC, Pope J, Bykerk VP. SAT0112 Guideline-based care improves outcomes that matter to patients: tighter control, less suffering, and greater well-being over the past decade in canadian ra patients Annals of the Rheumatic Diseases. 77: 919-919. DOI: 10.1136/Annrheumdis-2018-Eular.5579 |
0.44 |
|
2018 |
Kudaeva F, Speechley M, Klar N, Schieir O, Bartlett S, Hitchon C, Boire G, Haraoui B, Keystone E, Tin D, Thorne C, Bykerk V, Pope J. SAT0678 Seasonality of new early inflammatory arthritis cases: preliminary results from the canadian early arthritis cohort Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2018-Eular.2527 |
0.371 |
|
2017 |
Thorne C, Boire G, Chow A, Garces K, Liu F, Poulin-Costello M, Walker V, Haraoui B. Dose Escalation and Co-therapy Intensification Between Etanercept, Adalimumab, and Infliximab: The CADURA Study. The Open Rheumatology Journal. 11: 123-135. PMID 29296125 DOI: 10.2174/1874312901711010123 |
0.36 |
|
2017 |
Schulman E, Bartlett SJ, Schieir O, Andersen KM, Boire G, Pope JE, Hitchon C, Jamal S, Thorne CJ, Tin D, Keystone EC, Haraoui B, Goodman SM, Bykerk VP, Investigators C. Overweight and Obesity Reduce the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results from the Canadian Early Arthritis Cohort Study. Arthritis Care & Research. PMID 29193840 DOI: 10.1002/Acr.23457 |
0.351 |
|
2017 |
Nagaraj S, Barnabe C, Schieir O, Pope J, Bartlett SJ, Boire G, Keystone E, Tin D, Haraoui B, Thorne JC, Bykerk VP, Hitchon C. Early Rheumatoid Arthritis Presentation, Treatment and Outcomes in Aboriginal Patients in Canada: A Canadian Early Arthritis Cohort Study Analysis. Arthritis Care & Research. PMID 29125904 DOI: 10.1002/Acr.23470 |
0.409 |
|
2017 |
Jean S, Hudson M, Gamache P, Bessette L, Fortin PR, Boire G, Bernatsky S. Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study. Clinical Rheumatology. PMID 28828712 DOI: 10.1007/S10067-017-3796-1 |
0.383 |
|
2017 |
Barra LJ, Pope JE, Hitchon C, Boire G, Schieir O, Lin D, Thorne CJ, Tin D, Keystone EC, Haraoui B, Jamal S, Bykerk VP. The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis. Rheumatology (Oxford, England). PMID 28073956 DOI: 10.1093/Rheumatology/Kew474 |
0.416 |
|
2017 |
Schieir O, Bartlett S, Hitchon C, Pope J, Boire G, Haraoui B, Keystone E, Tin D, Thorne C, Bykerk V. SAT0122 Which multimorbid conditions are more prevalent around the time of early ra diagnosis and have the greatest impact on trajectories of disease activity in the first year? results from the canadian early arthritis cohort Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2017-Eular.6369 |
0.409 |
|
2017 |
Barnabe C, Schieir O, Hazlewood G, Pope J, Hitchon C, Bartlett S, Boire G, Keystone E, Tin D, Haraoui B, Bykerk V, Thorne C. THU0085 Time to remission and the achievement of sustained remission in patients with early rheumatoid arthritis: site variation analysis in therapeutic strategy from the canadian early arthritis cohort (CATCH) Annals of the Rheumatic Diseases. 76: 231-232. DOI: 10.1136/Annrheumdis-2017-Eular.5695 |
0.355 |
|
2017 |
Carrier N, Garant M, Marotta A, Fernandes ADB, Liang P, Masetto A, Gui Y, Savill J, Michienzi S, Maksymowych W, Boire G. FRI0047 Elevated 14-3-3eta levels predict worse radiographic outcomes in patients with recent-onset inflammatory arthritis in clinical remission Annals of the Rheumatic Diseases. 76: 496-497. DOI: 10.1136/Annrheumdis-2017-Eular.4085 |
0.367 |
|
2017 |
Lim S, Schieir O, Bartlett S, Boire G, Haraoui B, Keystone E, Tin D, Thorne C, Pope J, Bykerk V, Hitchon C. SAT0039 Large tender joints have the greatest impact on longitudinal trajectories of function in early rheumatoid arthritis Annals of the Rheumatic Diseases. 76: 781-782. DOI: 10.1136/Annrheumdis-2017-Eular.3328 |
0.338 |
|
2017 |
Sepriano A, Ramiro S, Landewé R, Heijde Dvd, Ohrndorf S, FitzGerald O, Backhaus M, Larché M, Homik J, Saraux A, Hammer H, Terslev L, Østergaard M, Burmester G, Combe B, ... ... Boire G, et al. OP0192 Adding ultrasound to the treat-to-target strategy shows no benefit in achievement of remission: results from the biodam cohort Annals of the Rheumatic Diseases. 76: 131-131. DOI: 10.1136/Annrheumdis-2017-Eular.1613 |
0.379 |
|
2016 |
Omair MA, Keystone E, Bykerk V, Lin D, Xiong J, Sun Y, Boire G, Thorne JC, Pope J, Hitchon C, Haraoui B, Tin D, Akhavan PS. SDAI 50 is more stringent than EULAR response measure and a better predictor of low disease state/remission in early rheumatoid arthritis in the first 6 months: Results from an Early Arthritis Cohort. Arthritis Care & Research. PMID 27564591 DOI: 10.1002/Acr.22983 |
0.405 |
|
2016 |
Hitchon CA, Boire G, Haraoui B, Keystone E, Pope J, Jamal S, Tin D, Thorne C, Bykerk VP. Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort. Rheumatology (Oxford, England). PMID 27330161 DOI: 10.1093/Rheumatology/Kew061 |
0.403 |
|
2016 |
Bykerk VP, Bingham CO, Choy EH, Lin D, Alten R, Christensen R, Furst DE, Hewlett S, Leong A, March L, Woodworth T, Boire G, Haraoui B, Hitchon C, Jamal S, et al. Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set. Rmd Open. 2: e000225. PMID 27252895 DOI: 10.1136/Rmdopen-2015-000225 |
0.383 |
|
2016 |
Lee JJ, Bykerk VP, Dresser GK, Boire G, Haraoui B, Hitchon C, Thorne C, Tin D, Jamal S, Keystone EC, Pope JE. Reduction in Serum Uric Acid May Be Related to Methotrexate Efficacy in Early Rheumatoid Arthritis: Data from the Canadian Early Arthritis Cohort (CATCH). Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders. 9: 37-43. PMID 27081318 DOI: 10.4137/Cmamd.S38092 |
0.393 |
|
2016 |
Carrier N, Marotta A, de Brum-Fernandes AJ, Liang P, Masetto A, Ménard HA, Maksymowych WP, Boire G. Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis. Arthritis Research & Therapy. 18: 37. PMID 26832367 DOI: 10.1186/S13075-016-0935-Z |
0.387 |
|
2016 |
Aberumand B, Bykerk V, Schieir O, Lin D, Boire G, Haraoui B, Hitchon CA, Thorne C, Tin D, Keystone EC, Jamal S, Pope JE. SAT0055 Treatment Response To Conventional Disease Modifying Anti-Rheumatic Drugs (Dmards) and Biologics in Seropositive and Seronegative Patients with Early Rheumatoid Arthritis: Results from Catch (Canadian Early Arthritis Cohort) Annals of the Rheumatic Diseases. 75: 683-684. DOI: 10.1136/Annrheumdis-2016-Eular.4483 |
0.374 |
|
2016 |
Bartlett SJ, Schieir O, Schulman E, Goodman SM, Zhang M, Lin D, Andersen KM, Boire G, Haraoui B, Hitchon C, Jamal S, Keystone E, Pope J, Tin D, Thorne JC, et al. OP0173 How Much of A Barrier Is Excess Weight and Smoking for Achieving Sustained Remission in Early RA? Results from The Canadian Early Arthritis Cohort Annals of the Rheumatic Diseases. 75: 121-121. DOI: 10.1136/Annrheumdis-2016-Eular.4373 |
0.315 |
|
2016 |
Carrier N, Marotta A, Maksymowych WP, Boire G. AB0090 Reactivity To Citrullinated Peptide of 14-3-3eta Protein Is Associated with Worse Radiographic Outcomes in Patients with Recent-Onset Inflammatory Arthritis Annals of the Rheumatic Diseases. 75: 927-928. DOI: 10.1136/Annrheumdis-2016-Eular.3717 |
0.388 |
|
2016 |
Kuriya B, Schieir O, Lin D, Pope J, Boire G, Haraoui B, Thorne C, Tin D, Hitchon C, Keystone E, Bykerk V. FRI0066 The 28-Joint Disease Activity Score (DAS28) Using C-Reactive Protein Yields Lower Thresholds Compared To Conventional DAS28 with Erythrocyte Sedimentation Rate in Early Rheumatoid Arthritis Annals of the Rheumatic Diseases. 75: 449-450. DOI: 10.1136/Annrheumdis-2016-Eular.2937 |
0.411 |
|
2016 |
Gottheil S, Pope J, Schieir O, Hazlewood G, Keystone E, Jamal S, Barnabe C, Boire G, Hitchon C, Thorne C, Bykerk V, Tin D, Haraoui P. OP0179 Comparing Initial Treatment Strategies with Methotrexate on First Use of Biologic Therapy: Results from The Canadian Early Arthritis Cohort Annals of the Rheumatic Diseases. 75: 124-125. DOI: 10.1136/Annrheumdis-2016-Eular.2103 |
0.393 |
|
2016 |
Boire G, Carrier N, Fernandes AJdB, Liang P, Masetto A, Gui Y, Savill J, Michienzi S, Menard HA, Maksymowych WP, Marotta A. THU0048 Testing of 14-3-3eta in Early Undifferentiated Polyarthritis Can Assist with Prioritizing Referrals of High Joint Damage Risk Patients To Rheumatologists Annals of the Rheumatic Diseases. 75: 195-195. DOI: 10.1136/Annrheumdis-2016-Eular.2081 |
0.423 |
|
2016 |
Ramiro S, Landewé R, Heijde Dvd, FitzGerald O, Østergaard M, Homik J, Elkayam O, Thorne JC, Larche M, Ferraccioli G, Backhaus M, Boire G, Combe B, Schaeverbeke T, Saraux A, et al. THU0067 Is Treat-To-Target Really Working? A Longitudinal Analysis in Biodam Annals of the Rheumatic Diseases. 75: 202-203. DOI: 10.1136/Annrheumdis-2016-Eular.1914 |
0.381 |
|
2016 |
Andersen KM, Bartlett SJ, Lin D, Schieir O, Boire G, Haraoui B, Hitchon C, Jamal S, Keystone E, Pope J, Tin D, Thorne C, Bykerk VP. THU0186 Does Early Steroid Use Increase The Likelihood of Achieving Remission at 6 Months in Early RA? Results from The Canadian Early Arthritis Cohort Annals of the Rheumatic Diseases. 75: 252-253. DOI: 10.1136/Annrheumdis-2016-Eular.1805 |
0.416 |
|
2016 |
Garces K, Thorne C, Boire G, Chow A, Poulin-Costello M, Walker V, Haraoui B. Comparison Of Dose Escalation And Costs Of Dose Escalation Between Patients With Rheumatoid Arthritis Initiating Biologic Treatment With Etanercept, Adalimumab, Or Infliximab Value in Health. 19. DOI: 10.1016/J.Jval.2016.03.1129 |
0.312 |
|
2015 |
Challener GJ, Jones JD, Pelzek AJ, Hamilton BJ, Boire G, de Brum-Fernandes AJ, Masetto A, Carrier N, Ménard HA, Silverman GJ, Rigby WF. Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis. The Journal of Rheumatology. PMID 26669911 DOI: 10.3899/Jrheum.150179 |
0.375 |
|
2015 |
Shu J, Bykerk VP, Boire G, Haraoui B, Hitchon C, Thorne JC, Tin D, Keystone EC, Pope JE. Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort. The Journal of Rheumatology. 42: 2023-8. PMID 26329342 DOI: 10.3899/Jrheum.150260 |
0.422 |
|
2015 |
Barnabe C, Sun Y, Boire G, Hitchon CA, Haraoui B, Thorne JC, Tin D, van der Heijde D, Curtis JR, Jamal S, Pope JE, Keystone EC, Bartlett S, Bykerk VP. Heterogeneous Disease Trajectories Explain Variable Radiographic, Function and Quality of Life Outcomes in the Canadian Early Arthritis Cohort (CATCH). Plos One. 10: e0135327. PMID 26301589 DOI: 10.1371/Journal.Pone.0135327 |
0.335 |
|
2015 |
Moura CS, Abrahamowicz M, Beauchamp ME, Lacaille D, Wang Y, Boire G, Fortin PR, Bessette L, Bombardier C, Widdifield J, Hanly JG, Feldman D, Maksymowych W, Peschken C, Barnabe C, et al. Early medication use in new-onset rheumatoid arthritis may delay joint replacement: results of a large population-based study. Arthritis Research & Therapy. 17: 197. PMID 26235697 DOI: 10.1186/S13075-015-0713-3 |
0.389 |
|
2015 |
Leblanc-Trudeau C, Dobkin PL, Carrier N, Cossette P, de Brum-Fernandes AJ, Liang P, Masetto A, Boire G. Depressive symptoms predict future simple disease activity index scores and simple disease activity index remission in a prospective cohort of patients with early inflammatory polyarthritis. Rheumatology (Oxford, England). PMID 26209789 DOI: 10.1093/Rheumatology/Kev272 |
0.323 |
|
2015 |
Maksymowych WP, Boire G, van Schaardenburg D, Wichuk S, Turk S, Boers M, Siminovitch KA, Bykerk V, Keystone E, Tak PP, van Kuijk AW, Landewé R, van der Heijde D, Murphy M, Marotta A. 14-3-3η Autoantibodies: Diagnostic Use in Early Rheumatoid Arthritis. The Journal of Rheumatology. 42: 1587-94. PMID 26178283 DOI: 10.3899/Jrheum.141385 |
0.434 |
|
2015 |
Curtis JR, Yang S, Chen L, Pope JE, Keystone EC, Haraoui B, Boire G, Thorne JC, Tin D, Hitchon CA, Bingham CO, Bykerk VP. Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients. Arthritis Care & Research. 67: 1345-53. PMID 25988705 DOI: 10.1002/Acr.22606 |
0.41 |
|
2015 |
Guzman J, Oen K, Huber AM, Watanabe Duffy K, Boire G, Shiff N, Berard RA, Levy DM, Stringer E, Scuccimarri R, Morishita K, Johnson N, Cabral DA, Rosenberg AM, Larché M, et al. The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort. Annals of the Rheumatic Diseases. PMID 25985972 DOI: 10.1136/Annrheumdis-2014-207164 |
0.375 |
|
2015 |
Hazlewood GS, Thorne JC, Pope JE, Lin D, Tin D, Boire G, Haraoui B, Hitchon CA, Keystone EC, Jamal S, Bykerk VP. The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis. Annals of the Rheumatic Diseases. PMID 25979945 DOI: 10.1136/Annrheumdis-2014-206504 |
0.371 |
|
2015 |
Yang G, Bykerk VP, Boire G, Hitchon CA, Thorne JC, Tin D, Haraoui B, Keystone EC, Pope JE. Does socioeconomic status affect outcomes in early inflammatory arthritis? Data from a canadian multisite suspected rheumatoid arthritis inception cohort. The Journal of Rheumatology. 42: 46-54. PMID 25399388 DOI: 10.3899/Jrheum.131382 |
0.386 |
|
2015 |
Wong LE, Huang WT, Pope JE, Haraoui B, Boire G, Thorne JC, Hitchon CA, Tin D, Keystone EC, Bykerk VP. Effect of age at menopause on disease presentation in early rheumatoid arthritis: results from the Canadian Early Arthritis Cohort. Arthritis Care & Research. 67: 616-23. PMID 25303739 DOI: 10.1002/Acr.22494 |
0.4 |
|
2015 |
Pope JE, Haraoui BP, Boire G, Hitchon C, Thorne C, Tin D, Keystone E, Bykerk VP. AB0276 Characteristics of Patients with Early Rheumatoid Arthritis (ERA) Over Time: Data from the Catch Cohort Demonstrate that More Patients Achieve Remission in Recent Years Annals of the Rheumatic Diseases. 74: 984-985. DOI: 10.1136/Annrheumdis-2015-Eular.5235 |
0.46 |
|
2015 |
Widdifield J, Moura C, Wang Y, Abrahamowicz M, Beauchamp M, Paterson M, Huang A, Boire G, Fortin P, Bessette L, Bombardier C, Hanly J, Feldman D, Bernatsky S. OP0020 The Influence of Drug Exposures on Joint Surgeries in Rheumatoid Arthritis Patients: Cross-Provincial Comparisons Annals of the Rheumatic Diseases. 74: 72.1-72. DOI: 10.1136/Annrheumdis-2015-Eular.4981 |
0.388 |
|
2015 |
Bartlett S, Bingham C, Lin D, Boire G, Hitchon C, Haraoui B, Keystone E, Tin D, Thorne J, Pope J, Bykerk V. SAT0368 How Patients Self-Manage Rheumatoid Arthritis Flares: Findings from Catch Annals of the Rheumatic Diseases. 74: 792.3-793. DOI: 10.1136/Annrheumdis-2015-Eular.3144 |
0.404 |
|
2015 |
Barnabe C, Bartlett S, Sun Y, Boire G, Hitchon C, Keystone E, Haraoui B, Thorne J, Tin D, Pope J, Bykerk V. THU0337 Worse Disease Trajectory in Early RA Patients is Associated with Lower Improvements in Health Related Quality of Life; Results from a Multicenter Early RA Cohort Annals of the Rheumatic Diseases. 74: 317.2-318. DOI: 10.1136/Annrheumdis-2015-Eular.2776 |
0.351 |
|
2015 |
Lee JJ, Bykerk VP, Dresser GK, Boire G, Haraoui B, Hitchon C, Thorne C, Tin D, Jamal S, Keystone EC, Pope JE. THU0149 Does Methotrexate Lower Serum Uric Acid Levels? Data from the Catch Cohort Annals of the Rheumatic Diseases. 74: 248-248. DOI: 10.1136/Annrheumdis-2015-Eular.2595 |
0.333 |
|
2015 |
Goodman S, Ma Y, Zhang W, Schulman E, Bartlett S, Andersen K, Hitchon C, Boire G, Jamal S, Thorne J, Tin D, Keystone E, Haraoui B, Pope J, Bykerk V. OP0178 Body Mass Index is an Independent Risk Factor for not Achieving Sustained Remission in Early Rheumatoid Arthritis: Results from the Catch Observational Study Annals of the Rheumatic Diseases. 74: 138.2-139. DOI: 10.1136/Annrheumdis-2015-Eular.1973 |
0.382 |
|
2015 |
Bykerk V, Kim Y, Lin D, Bartlett S, Boire G, Hitchon C, Haraoui B, Keystone E, Tin D, Thorne J, Pope J, Salmon J. AB1188 Patient Reported “Negative” Life Events That Cause Stress Can Impact Patient Reported Outcomes in Early Rheumatoid Arthritis; An Analysis of the Catch Study Annals of the Rheumatic Diseases. 74: 1300.2-1300. DOI: 10.1136/Annrheumdis-2015-Eular.1809 |
0.371 |
|
2014 |
Bernatsky S, Dekis A, Hudson M, Pineau CA, Boire G, Fortin PR, Bessette L, Jean S, Chetaille AL, Belisle P, Bergeron L, Feldman DE, Joseph L. Rheumatoid arthritis prevalence in Quebec. Bmc Research Notes. 7: 937. PMID 25527187 DOI: 10.1186/1756-0500-7-937 |
0.384 |
|
2014 |
Kuriya B, Xiong J, Boire G, Haraoui B, Hitchon C, Pope J, Thorne JC, Tin D, Keystone EC, Bykerk V. Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis--results from the Canadian Early Arthritis Cohort (CATCH). The Journal of Rheumatology. 41: 2161-6. PMID 25274902 DOI: 10.3899/Jrheum.140137 |
0.369 |
|
2014 |
Barra L, Pope JE, Orav JE, Boire G, Haraoui B, Hitchon C, Keystone EC, Thorne JC, Tin D, Bykerk VP. Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis. The Journal of Rheumatology. 41: 2361-9. PMID 25274884 DOI: 10.3899/Jrheum.140082 |
0.44 |
|
2014 |
Guzman J, Oen K, Tucker LB, Huber AM, Shiff N, Boire G, Scuccimarri R, Berard R, Tse SM, Morishita K, Stringer E, Johnson N, Levy DM, Duffy KW, Cabral DA, et al. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort. Annals of the Rheumatic Diseases. PMID 24842571 DOI: 10.1136/Annrheumdis-2014-205372 |
0.343 |
|
2014 |
Jones JD, Hamilton BJ, Challener GJ, de Brum-Fernandes AJ, Cossette P, Liang P, Masetto A, Ménard HA, Carrier N, Boyle DL, Rosengren S, Boire G, Rigby WF. Serum C-X-C motif chemokine 13 is elevated in early and established rheumatoid arthritis and correlates with rheumatoid factor levels. Arthritis Research & Therapy. 16: R103. PMID 24766912 DOI: 10.1186/Ar4552 |
0.422 |
|
2014 |
Maksymowych WP, van der Heijde D, Allaart CF, Landewé R, Boire G, Tak PP, Gui Y, Ghahary A, Kilani R, Marotta A. 14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage. Arthritis Research & Therapy. 16: R99. PMID 24751211 DOI: 10.1186/Ar4547 |
0.405 |
|
2014 |
Arnold MB, Bykerk VP, Boire G, Haraoui BP, Hitchon C, Thorne C, Keystone EC, Pope JE, Ahluwalia V, Akhavan P, Arbillaga H, Baron M, Bell M, Bensen W, Cividino A, et al. Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort Rheumatology (United Kingdom). 53: 1075-1086. PMID 24501240 DOI: 10.1093/Rheumatology/Ket449 |
0.393 |
|
2014 |
Choy T, Bykerk VP, Boire G, Haraoui BP, Hitchon C, Thorne C, Keystone EC, Pope JE. Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort. Rheumatology (Oxford, England). 53: 482-90. PMID 24241035 DOI: 10.1093/Rheumatology/Ket366 |
0.346 |
|
2014 |
Barnabe C, Xiong J, Pope JE, Boire G, Hitchon C, Haraoui B, Carter Thorne J, Tin D, Keystone EC, Bykerk VP. Factors associated with time to diagnosis in early rheumatoid arthritis. Rheumatology International. 34: 85-92. PMID 23989941 DOI: 10.1007/S00296-013-2846-5 |
0.393 |
|
2014 |
Bykerk V, Bingham C, Choy E, Boire G, Haraoui B, Lin D, Pope J, Thorne J, Hitchon C, Tin D, Keystone E, Bartlett S. FRI0103 The Omeract Preliminary Flare Questionnaire (PFQ) is Responsive to Change and Able to Detect Clinically Important Worsening Indicating Need for Treatment Change in the Canadian Early Arthritis Cohort Annals of the Rheumatic Diseases. 73: 418.2-419. DOI: 10.1136/Annrheumdis-2014-Eular.4489 |
0.406 |
|
2014 |
Visser K, Bartlett S, Bingham CO, Choy EH, Lin D, Boire G, Haraoui B, Hitchon C, Keystone EE, Thorne C, Tin D, Bykerk VP. THU0273 Changes in Patient-Reported Joint Counts and Composite Indices Can Identify Flare of Disease Activity in Recent Onset Annals of the Rheumatic Diseases. 73: 277-278. DOI: 10.1136/Annrheumdis-2014-Eular.4253 |
0.435 |
|
2014 |
Bartlett SJ, Bingham CO, Choy E, Boire G, Haraoui B, Lin D, Pope JE, Thorne C, Hitchon CA, Tin D, Keystone EC, Bykerk V. SAT0097 Assessing Significant Flares in Rheumatoid Arthritis: Validity of the Omeract Preliminary Flare Questionnaire (PFQ) in the Canadian Early Arthritis Cohort Annals of the Rheumatic Diseases. 73: 625-625. DOI: 10.1136/Annrheumdis-2014-Eular.3928 |
0.417 |
|
2014 |
Boire G, Carrier N, Brum-Fernandes AJd, Liang P, Masetto A, Gui Y, Murphy M, Maksymowych WP, Marotta A. SAT0041 14-3-3Eta Predicts Radiographic Progression in Recent-Onset Polyarthritis Patients Annals of the Rheumatic Diseases. 73: 603-604. DOI: 10.1136/Annrheumdis-2014-Eular.3299 |
0.374 |
|
2014 |
Moura C, Abrahamowicz M, Beauchamp M, Lacaille D, Wang Y, Bombardier C, Widdifield J, Hanly J, Boire G, Feldman D, Maksymowych W, Peschken C, Barnabe C, Edworthy S, Fortin P, et al. THU0120 Is Early DMARD Use Associated with Less Joint Replacement Surgery? an Analysis of 5,199 Incident Rheumatoid Arthritis (RA) Patients Annals of the Rheumatic Diseases. 73: 219.2-220. DOI: 10.1136/Annrheumdis-2014-Eular.3061 |
0.441 |
|
2014 |
Barnabe C, Huang W, Sun Y, Boire G, Hitchon C, Keystone E, Thorne J, Haraoui B, Curtis J, Tin D, Pope J, Bykerk V. OP0038 Socio-Demographic and Health Status Characteristics Explain Clinical Outcome Trajectories in Early Inflammatory Arthritis (EIA) Annals of the Rheumatic Diseases. 73: 74.2-74. DOI: 10.1136/Annrheumdis-2014-Eular.2946 |
0.321 |
|
2014 |
Curtis J, Yang S, Chen L, Pope J, Keystone E, Haraqui B, Boire G, Thorne J, Tin D, Hitchon C, Bingham C, Bykerk V. THU0266 Determining the Absolute Change in the Clinical Disease Activity Index (CDAI) to Define A Minimally Important Difference: Annals of the Rheumatic Diseases. 73: 275.1-275. DOI: 10.1136/Annrheumdis-2014-Eular.2945 |
0.426 |
|
2014 |
Yang G, Bykerk V, Haraoui BP, Thorne C, Tin D, Hitchon C, Boire G, Keystone E, Pope JE. THU0256 Does Socioeconomic Status Affect Outcomes in Early Rheumatoid Arthritis? Data from A Multi-Site Canadian Inception Cohort Annals of the Rheumatic Diseases. 73: 271-271. DOI: 10.1136/Annrheumdis-2014-Eular.2737 |
0.389 |
|
2014 |
Shu J, Bykerk V, Boire G, Haraoui B, Hitchon C, Thorne C, Tin D, Keystone E, Pope J. AB0251 The Impact of Missing Anti-Citrullinated Protein Antibody (ACPA) Serology on Outcomes in Early Rheumatoid Arthritis: Results from Catch (Canadian Early Arthritis Cohort) Annals of the Rheumatic Diseases. 73: 886-887. DOI: 10.1136/Annrheumdis-2014-Eular.2635 |
0.45 |
|
2013 |
Harris JA, Bykerk VP, Hitchon CA, Keystone EC, Thorne JC, Boire G, Haraoui B, Hazlewood G, Bonner AJ, Pope JE. Determining best practices in early rheumatoid arthritis by comparing differences in treatment at sites in the Canadian Early Arthritis Cohort. The Journal of Rheumatology. 40: 1823-30. PMID 24037554 DOI: 10.3899/Jrheum.121316 |
0.392 |
|
2013 |
Masetto A, Beaulieu MC, Boire G. Prevention of rheumatoid arthritis: the very first steps. The Journal of Rheumatology. 40: 752-4. PMID 23728185 DOI: 10.3899/Jrheum.130326 |
0.429 |
|
2013 |
Barra L, Bykerk V, Pope JE, Haraoui BP, Hitchon CA, Thorne JC, Keystone EC, Boire G. Anticitrullinated protein antibodies and rheumatoid factor fluctuate in early inflammatory arthritis and do not predict clinical outcomes. The Journal of Rheumatology. 40: 1259-67. PMID 23378461 DOI: 10.3899/Jrheum.120736 |
0.383 |
|
2013 |
Lee YC, Lu B, Boire G, Haraoui BP, Hitchon CA, Pope JE, Thorne JC, Keystone EC, Solomon DH, Bykerk VP. Incidence and predictors of secondary fibromyalgia in an early arthritis cohort. Annals of the Rheumatic Diseases. 72: 949-54. PMID 22791744 DOI: 10.1136/Annrheumdis-2012-201506 |
0.382 |
|
2013 |
Mussen L, Boyd T, Bykerk V, de Leon F, Li L, Boire G, Hitchon C, Haraoui B, Thorne JC, Pope J. Low prevalence of work disability in early inflammatory arthritis (EIA) and early rheumatoid arthritis at enrollment into a multi-site registry: results from the catch cohort. Rheumatology International. 33: 457-65. PMID 22461187 DOI: 10.1007/S00296-012-2407-3 |
0.382 |
|
2013 |
Boyd TA, Bonner A, Thorne C, Boire G, Hitchon C, Haraoui BP, Keystone EC, Bykerk VP, Pope JE. The relationship between function and disease activity as measured by the HAQ and DAS28 varies over time and by rheumatoid factor status in early inflammatory arthritis (EIA). results from the CATCH cohort Open Rheumatology Journal. 7: 58-63. DOI: 10.2174/1874312901307010058 |
0.327 |
|
2013 |
April P-, Cabana F, Beaulieu M-, Beaulieu M, Roux S, Boire G. THU0381 Up to Half of First Fragility Fractures (FF), and a Third of Recurrent FF, Occur in Patients with Low or Moderate Estimated Frax® 10-Year Fracture Risk: Results from the Optimus Initiative Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.909 |
0.307 |
|
2013 |
Hazlewood G, Thorne C, Pope J, Boire G, Haraoui B, Hitchon C, Keystone E, Tin D, Bykerk V, investigators C. THU0240 The Comparative Effectiveness of Oral Methotrexate Versus Subcutaneous Methotrexate for the Initial Treatment of Early Rheumatoid Arthritis Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.768 |
0.43 |
|
2013 |
Omair M, Akhavan P, Keystone EC, Xiong J, Boire G, Pope JE, Thorne JC, Hitchon CA, Haraoui B, Tin D, Weber DA, Bykerk VP, Investigators C. AB0768 Relationship between das28 1.2 and sdai50 responses in rheumatoid arthritis Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.3090 |
0.388 |
|
2013 |
Bykerk VP, Pope JE, Xiong J, Boire G, Haraoui B, Thorne JC, Hitchon CA, Tin D, Keystone EC. SAT0032 Comparison of Das28 Using ESR and CRP in an Early Rheumatoid Arthritis Cohort Annals of the Rheumatic Diseases. 72: A590.2-A591. DOI: 10.1136/Annrheumdis-2013-Eular.1758 |
0.412 |
|
2013 |
Wong LE, Xiong J, Boire G, Haraoui B, Pope JE, Thorne JC, Hitchon CA, Tin D, Keystone EC, Bykerk VP. SAT0031 Effect of Duration in Menopause on Disease Presentation in Early Rheumatoid Arthritis (RA) Annals of the Rheumatic Diseases. 72: A590.1-A590. DOI: 10.1136/Annrheumdis-2013-Eular.1757 |
0.378 |
|
2013 |
Bartlett SJ, Bingham CO, Choy E, Xiong J, Boire G, Haraoui B, Pope JE, Thorne JC, Hitchon CA, Tin D, Keystone EC, Bykerk VP. SAT0018 Establishing the Content Validity of Omeract Preliminary Flare Questions (PFQ) for Detecting and Measuring Disease Exacerbations in Rheumatoid Arthritis Annals of the Rheumatic Diseases. 72: A585.1-A585. DOI: 10.1136/Annrheumdis-2013-Eular.1744 |
0.404 |
|
2013 |
Choy T, Bykerk VP, Haraoui BP, Boire G, Hitchon C, Thorne C, Keystone E, Pope JE. FRI0050 Physician global assessment at three months is strongly predictive of disease activity at 12 months in early rheumatoid arthritis. results from the catch cohort. Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.1177 |
0.411 |
|
2013 |
Arnold M, Bykerk VP, Haraoui BP, Boire G, Hitchon C, Thorne C, Keystone E, Pope JE. FRI0049 Are there differences between young and older onset early rheumatoid arthritis (RA) and does this impact outcomes? an analysis from the catch cohort. Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.1176 |
0.435 |
|
2013 |
Beaulieu M-, Cabana F, Beaulieu M, Roux S, Boire G. SAT0367 Management of fragility fractures: Impact of the optimus initiative on family physicians Annals of the Rheumatic Diseases. 71: 596-596. DOI: 10.1136/Annrheumdis-2012-Eular.3313 |
0.305 |
|
2013 |
Bykerk VP, Bartlett SJ, Choy E, Boire G, Hitchon C, Pope J, Thorne C, Haraoui B, Keystone E, Bingham CO. SAT0117 Early RA patients reporting a flare identify more tender than swollen joints Annals of the Rheumatic Diseases. 71: 509-510. DOI: 10.1136/Annrheumdis-2012-Eular.3064 |
0.4 |
|
2013 |
Pyne L, Bykerk V, Hitchon C, Keystone E, Thorne C, Boire G, Haraoui BP, Bonner A, Pope J. SAT0101 Das does not predict increasing treatment in early rheumatoid arthritis (ERA): Results from the catch study Annals of the Rheumatic Diseases. 71: 504-504. DOI: 10.1136/Annrheumdis-2012-Eular.3048 |
0.36 |
|
2013 |
Akhavan P, Bykerk V, Sun Y, Choi M, Pope J, Hitchon C, Boire G, Haraoui B, Thorne C, Tin D, Keystone E. FRI0091 Discrepancy between patient and physician global assessments in early rheumatoid arthritis (RA) – the need for swollen joint evaluation Annals of the Rheumatic Diseases. 71: 340-340. DOI: 10.1136/Annrheumdis-2012-Eular.2548 |
0.425 |
|
2013 |
Harris J, Bykerk V, Hitchon C, Keystone E, Thorne C, Boire G, Haraoui B, Hazelwood G, Bonner A, Pope J. FRI0078 Can we improve outcomes in early rheumatoid arthritis (ERA) by determining best practices? An analysis of the canadian era cohort (CATCH): Annals of the Rheumatic Diseases. 71: 336.1-336. DOI: 10.1136/Annrheumdis-2012-Eular.2535 |
0.369 |
|
2013 |
Bykerk VP, Bartlett SJ, Choy E, Boire G, Hitchon C, Pope J, Thorne C, Haraoui B, Keystone E, Bingham CO. THU0082 An evaluation of flare in patients with early rheumatoid arthritis using the omeract preliminary flare questionnaire Annals of the Rheumatic Diseases. 71: 180-181. DOI: 10.1136/Annrheumdis-2012-Eular.2047 |
0.399 |
|
2012 |
Pyne L, Bykerk VP, Boire G, Haraoui B, Hitchon C, Thorne JC, Keystone EC, Pope JE. Increasing treatment in early rheumatoid arthritis is not determined by the disease activity score but by physician global assessment: results from the CATCH study. The Journal of Rheumatology. 39: 2081-7. PMID 22942265 DOI: 10.3899/Jrheum.120520 |
0.416 |
|
2012 |
Tavares R, Pope JE, Tremblay JL, Thorne C, Bykerk VP, Lazovskis J, Blocka KL, Bell MJ, Lacaille D, Hitchon CA, Fitzgerald AA, Fidler WK, Bookman AA, Henderson JM, Mosher DP, ... ... Boire G, et al. Time to disease-modifying antirheumatic drug treatment in rheumatoid arthritis and its predictors: a national, multicenter, retrospective cohort. The Journal of Rheumatology. 39: 2088-97. PMID 22896027 DOI: 10.3899/Jrheum.120100 |
0.393 |
|
2012 |
Bykerk VP, Jamal S, Boire G, Hitchon CA, Haraoui B, Pope JE, Thorne JC, Sun Y, Keystone EC. The Canadian Early Arthritis Cohort (CATCH): patients with new-onset synovitis meeting the 2010 ACR/EULAR classification criteria but not the 1987 ACR classification criteria present with less severe disease activity. The Journal of Rheumatology. 39: 2071-80. PMID 22896026 DOI: 10.3899/Jrheum.120029 |
0.43 |
|
2012 |
McKeown E, Bykerk VP, De Leon F, Bonner A, Thorne C, Hitchon CA, Boire G, Haraoui B, Ferland DS, Keystone EC, Pope JE. Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort. Rheumatology (Oxford, England). 51: 1662-9. PMID 22539481 DOI: 10.1093/Rheumatology/Kes079 |
0.347 |
|
2012 |
Kuriya B, Sun Y, Boire G, Haraoui B, Hitchon C, Pope JE, Thorne JC, Keystone EC, Bykerk VP. Remission in early rheumatoid arthritis -- a comparison of new ACR/EULAR remission criteria to established criteria. The Journal of Rheumatology. 39: 1155-8. PMID 22505708 DOI: 10.3899/Jrheum.111341 |
0.403 |
|
2011 |
Tavares R, Pope JE, Tremblay JL, Thorne C, Bykerk VP, Lazovskis J, Blocka KL, Bell MJ, Lacaille D, Hitchon CA, Fitzgerald AA, Fidler WK, Bookman AA, Henderson JM, Mosher DP, ... ... Boire G, et al. Early management of newly diagnosed rheumatoid arthritis by Canadian rheumatologists: a national, multicenter, retrospective cohort. The Journal of Rheumatology. 38: 2342-5. PMID 21885485 DOI: 10.3899/Jrheum.110249 |
0.423 |
|
2011 |
Budarf ML, Goyette P, Boucher G, Lian J, Graham RR, Claudio JO, Hudson T, Gladman D, Clarke AE, Pope JE, Peschken C, Smith CD, Hanly J, Rich E, Boire G, et al. A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles. Genes and Immunity. 12: 51-8. PMID 20962850 DOI: 10.1038/Gene.2010.47 |
0.301 |
|
2011 |
Durand M, Boire G, Komarova SV, Dixon SJ, Sims SM, Harrison RE, Nabavi N, Maria O, Manolson MF, Mizianty M, Kurgan L, de Brum-Fernandes AJ. The increased in vitro osteoclastogenesis in patients with rheumatoid arthritis is due to increased percentage of precursors and decreased apoptosis - the In Vitro Osteoclast Differentiation in Arthritis (IODA) study. Bone. 48: 588-96. PMID 20959150 DOI: 10.1016/J.Bone.2010.10.167 |
0.397 |
|
2010 |
Cheng CK, McDonald-Blumer H, Boire G, Pope JE, Haraoui B, Hitchon CA, Thorne C, Sun Y, Bykerk VP. Care gap in patients with early inflammatory arthritis with a high fracture risk identified using FRAX(®). The Journal of Rheumatology. 37: 2221-5. PMID 20716658 DOI: 10.3899/Jrheum.091368 |
0.307 |
|
2010 |
Guzian MC, Carrier N, Cossette P, de Brum-Fernandes AJ, Liang P, Ménard HA, Boire G. Outcomes in recent-onset inflammatory polyarthritis differ according to initial titers, persistence over time, and specificity of the autoantibodies. Arthritis Care & Research. 62: 1624-32. PMID 20617532 DOI: 10.1002/Acr.20288 |
0.375 |
|
2010 |
Oen K, Duffy CM, Tse SM, Ramsey S, Ellsworth J, Chédeville G, Chetaille AL, Saint-Cyr C, Cabral DA, Spiegel LR, Schneider R, Lang B, Huber AM, Dancey P, Silverman E, ... ... Boire G, et al. Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort. Arthritis Care & Research. 62: 527-36. PMID 20391508 DOI: 10.1002/Acr.20044 |
0.428 |
|
2009 |
Oen K, Tucker L, Huber AM, Miettunen P, Scuccimarri R, Campillo S, Cabral DA, Feldman BM, Tse S, Chédeville G, Spiegel L, Schneider R, Lang B, Ellsworth J, Ramsey S, ... ... Boire G, et al. Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study. Arthritis and Rheumatism. 61: 1077-86. PMID 19644903 DOI: 10.1002/Art.24539 |
0.408 |
|
2009 |
Carrier N, Cossette P, Daniel C, de Brum-Fernandes A, Liang P, Ménard HA, Boire G. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies. Arthritis and Rheumatism. 60: 698-707. PMID 19248090 DOI: 10.1002/Art.24353 |
0.431 |
|
2008 |
Edworthy S, Zummer M, Garner S, Boire G, Leclercq S, Bykerk V, Kraag G, Markland J, Thomas D, Thomson J, Henderson J. Smoldering rheumatoid arthritis: is the Canadian healthcare system neglecting a significant disease population? The Journal of Rheumatology. 35: 1506-12. PMID 18597407 |
0.307 |
|
2007 |
Perreault J, Perreault JP, Boire G. Ro-associated Y RNAs in metazoans: evolution and diversification. Molecular Biology and Evolution. 24: 1678-89. PMID 17470436 DOI: 10.1093/Molbev/Msm084 |
0.317 |
|
2006 |
Simard N, Boire G, de Brum-Fernandes AJ, St-Pierre Y. A novel approach to measure the contribution of matrix metalloproteinase in the overall net proteolytic activity present in synovial fluids of patients with arthritis. Arthritis Research & Therapy. 8: R125. PMID 16859524 DOI: 10.1186/Ar2014 |
0.339 |
|
2005 |
Boire G, Cossette P, de Brum-Fernandes AJ, Liang P, Niyonsenga T, Zhou ZJ, Carrier N, Daniel C, Ménard HA. Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis. Arthritis Research & Therapy. 7: R592-603. PMID 15899046 DOI: 10.1186/Ar1719 |
0.377 |
|
2005 |
Perreault J, Noël JF, Brière F, Cousineau B, Lucier JF, Perreault JP, Boire G. Retropseudogenes derived from the human Ro/SS-A autoantigen-associated hY RNAs. Nucleic Acids Research. 33: 2032-41. PMID 15817567 DOI: 10.1093/Nar/Gki504 |
0.727 |
|
2001 |
Gendron M, Roberge D, Boire G. Heterogeneity of human Ro ribonucleoproteins (RNPS): nuclear retention of Ro RNPS containing the human hY5 RNA in human and mouse cells. Clinical and Experimental Immunology. 125: 162-8. PMID 11472440 DOI: 10.1046/J.1365-2249.2001.01566.X |
0.346 |
|
2000 |
Bouffard P, Barbar E, Brière F, Boire G. Interaction cloning and characterization of RoBPI, a novel protein binding to human Ro ribonucleoproteins. Rna (New York, N.Y.). 6: 66-78. PMID 10668799 DOI: 10.1017/S1355838200990277 |
0.728 |
|
1999 |
Bouffard P, Brière F, Wellinger RJ, Boire G. Identification of ribonucleoprotein (RNP)-specific protein interactions using a yeast RNP interaction trap assay (RITA). Biotechniques. 27: 790-6. PMID 10524322 DOI: 10.2144/99274Rr02 |
0.727 |
|
1996 |
Granger D, Gendron M, Tremblay A, Chabot B, Ménard HA, Boire G. RNA-labelled Ro and La ribonucleoprotein complexes reassembled in vitro; characterization by gel shift analysis. Clinical and Experimental Immunology. 106: 498-503. PMID 8973618 DOI: 10.1046/J.1365-2249.1996.D01-861.X |
0.344 |
|
1995 |
Boire G, Gendron M, Monast N, Bastin B, Ménard HA. Purification of antigenically intact Ro ribonucleoproteins; biochemical and immunological evidence that the 52-kD protein is not a Ro protein. Clinical and Experimental Immunology. 100: 489-98. PMID 7774061 DOI: 10.1111/J.1365-2249.1995.Tb03728.X |
0.303 |
|
1995 |
Després N, Talbot G, Plouffe B, Boire G, Ménard HA. Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera. Journal of Clinical Investigation. 95: 1891-1896. PMID 7706496 DOI: 10.1172/Jci117870 |
0.425 |
|
1995 |
Muller S, Boire G, Ossondo M, Ricchiuti V, Smadja D, Vernant J, Ozden S. IgG Autoantibody Response in HTLV-I-Infected Patients Clinical Immunology and Immunopathology. 77: 282-290. PMID 7586738 DOI: 10.1006/Clin.1995.1154 |
0.308 |
|
1995 |
Boulanger C, Chabot B, Ménard HA, Boire G. Autoantibodies in human anti-Ro sera specifically recognize deproteinized hY5 Ro RNA. Clinical and Experimental Immunology. 99: 29-36. PMID 7529149 DOI: 10.1111/J.1365-2249.1995.Tb03468.X |
0.342 |
|
1993 |
Dalpé G, Fernandes F, Richard C, Boire G, Ménard HA. Heterogeneity of ANCA sera showing atypical, peripheral and classical cytoplasmic immunofluorescence patterns. Advances in Experimental Medicine and Biology. 336: 239-43. PMID 8296612 DOI: 10.1007/978-1-4757-9182-2_35 |
0.332 |
|
1991 |
Boire G, Lopez-Longo FJ, Lapointe S, Ménard HA. Sera from patients with autoimmune disease recognize conformational determinants on the 60-kd Ro/SS-A protein Arthritis and Rheumatism. 34: 722-730. PMID 1711323 DOI: 10.1002/Art.1780340613 |
0.31 |
|
Show low-probability matches. |